Luke specialises in biotechnological and biomedical inventions. He has experience in patent drafting, filing and prosecution, infringement, patentability, supplementary protection certificates (SPCs), and IP transactions. Luke advises clients ranging from start-up enterprises, individual inventors, universities, and large multinational corporations.
Luke obtained a Ph.D. at Cambridge University (UK) after graduating from Trinity College Dublin with a first class honours degree in Natural Sciences, majoring in Biochemistry with Cell Biology. He has an extensive understanding of the biological sciences, with particular expertise in molecular biology, biochemistry, genetics, immunology, and biotechnology.
Well placed to advise clients in the pharmaceutical industry, Luke worked in both R&D and manufacturing at two multinational “Big Pharma” companies before joining FRKelly.
Learn more about the upcoming Unified Patent Court with our newest article, covering UPC Infringement Actions.… https://t.co/exfuJNC8jd
We will be attending the 73rd APAA Council Meeting in Busan in a few weeks. Sumi Nadarajah and Paul Keane look forw… https://t.co/kolTAQqyLg
The newest article in our UP/UPC series covers costs for the upcoming Unitary Patent! Check it out to learn more an… https://t.co/5p5QI9ouf7